Intellectual and Developmental Disability: Healthcare Financing by Ervin, David A. & Merrick, Joav
Georgia State University
ScholarWorks @ Georgia State University
Public Health Faculty Publications School of Public Health
2014
Intellectual and Developmental Disability:
Healthcare Financing
David A. Ervin
National Institute of Child Health and Development, Israel, dervin@tre.org
Joav Merrick
Georgia State University, jmerrick@zahav.net.il
Follow this and additional works at: https://scholarworks.gsu.edu/iph_facpub
Part of the Public Health Commons
This Article is brought to you for free and open access by the School of Public Health at ScholarWorks @ Georgia State University. It has been accepted
for inclusion in Public Health Faculty Publications by an authorized administrator of ScholarWorks @ Georgia State University. For more information,
please contact scholarworks@gsu.edu.
Recommended Citation
J. Merrick and D. A. Ervin . 2014. Intellectual and developmental disability: Healthcare financing Frontiers in Public Health, 2. doi:
10.3389/fpubh.2014.00160
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PUBLIC HEALTH
OPINION ARTICLE
published: 24 September 2014
doi: 10.3389/fpubh.2014.00160
Intellectual and developmental disability: healthcare
financing
David A. Ervin1,2*† and Joav Merrick 2,3,4,5,6†
1 The Resource Exchange, Colorado Springs, CO, USA
2 National Institute of Child Health and Human Development, Jerusalem, Israel
3 Health Services, Division for Intellectual and Developmental Disabilities, Ministry of Social Affairs and Social Services, Jerusalem, Israel
4 Division of Pediatrics, Hadassah Hebrew University Medical Center, Jerusalem, Israel
5 Kentucky Children’s Hospital, University of Kentucky College of Medicine, Lexington, KY, USA
6 Center for Healthy Development, School of Public Health, Georgia State University, Atlanta, GA, USA
*Correspondence: dervin@tre.org
†Present address:
David A. Ervin, The Resource Exchange, Inc., Colorado Springs, CO, USA
Joav Merrick, Health Services, Division for Intellectual and Developmental Disabilities, Ministry of Social Affairs and Social Services, Jerusalem, Israel
Edited by:
Richard Eugene Frye, Harvard University, USA
Reviewed by:
Corrado Romano, Istituto di Ricovero e Cura a carattere scientifico (IRCSS) Associazione Oasi Maria Santissima, Italy
Jesus Peinado, Texas Tech University Health Sciences Center, USA
Keywords: intellectual and developmental disability, healthcare Financing, World Health Organization, health care, neurodevelopmental and related
disabilities
INTRODUCTION
The World Health Organization (WHO)
estimates global spending on healthcare
at $6.5 trillion, approximately 10.5% of
the world’s gross domestic product. The
United States’(US) share of that spending is
$2.6 trillion, essentially quadrupling since
1980. The 2010 United States Patient Pro-
tection and Affordable Care Act (PPACA),
also known as Obamacare, has stimulated
extensive debate over the way in which
healthcare is financed, and whether or
not the costs of healthcare are sustain-
able. Among publicly funded healthcare in
the US, Medicaid and Medicare are pri-
mary sources of funding. In federal fis-
cal year 2012, Medicaid spending on acute
health exceeded $275.4 billion, while a fur-
ther $122.7 billion expended in Medic-
aid long term services and supports. The
impact of an aging population worldwide
(the so-called “wave of wisdom”), as the
Baby Boomer generation reaches senior
status, and attendant increases in chronic
conditions, will be a substantial driver of
healthcare costs in the future.
Among people with intellectual and
developmental disabilities (IDD), cost esti-
mates vary depending on a range of factors.
Some children with IDD, for example, are
covered for at least some healthcare needs
by private insurance policies held by their
parents, while other children and most
adults with IDD rely heavily on Medicaid
and, to a lesser extent, Medicare and other
publicly financed healthcare options. In
many US states, certain nursing and home
health services are presumed to be part of
funding of home and community-based
service (HCBS) medicaid waiver services
(typically considered part of residential ser-
vice reimbursements under these waivers),
and rely on medicaid state plans for other
acute health services. There are also wide
ranges of estimates of uncompensated care
that, when combined with other variables
that are difficult to control, make accurate
aggregate cost estimates difficult. Biren-
baum and Cohen (1) offer a review of
healthcare utilization and costs in general
for people with IDD.
FINANCING HEALTHCARE FOR THIS
POPULATION
There are a number of factors that are likely
to contribute to the costs of healthcare
for people with IDD, which will require
thoughtful analyses as financing systems
continue to evolve. People with IDD are
living longer and experiencing declines
in health that ordinarily accompany the
aging process. The life expectancy for peo-
ple with IDD is similar to that of the
general population, with the mean age at
death ranging from the mid-50s (for those
with more severe disabilities or Down syn-
drome) to the early 70s for adults with mild
to moderate IDD (2, 3). The number of
adults with IDD aged 60 years and older is
expected to reach 1.2 million by 2030. This
increase in the lifespan of individuals with
developmental disabilities will inevitably
drive healthcare costs for the foreseeable
future.
There are also certain chronic condi-
tions that frequently are found among peo-
ple with IDD that are known drivers of
healthcare costs. In a 2012 study of nearly
1,000 adults with IDD in the US, two thirds
had two or more co-morbidities, including
obesity and chronic mental health needs.
More than 40% of these adults were diag-
nosed with four or more chronic condi-
tions in addition to IDD (4).
While we recognize these challenges to
delivering high-quality and affordable, sus-
tainable healthcare to people with IDD, we
must also acknowledge that obstacles to
accessing the level of care required of these
particular circumstances persist and con-
tribute to a higher cost of healthcare. To
the extent that barriers prevent people with
IDD accessing health promotion resources
and preventative healthcare through pri-
mary care, conditions are left unaddressed
until they require far more extensive and
expensive interventions.
NEW AND EMERGING MODELS
Models that address the costs of health-
care for people with IDD, while achiev-
ing high-quality care and outcomes are
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emerging. States and practitioners alike
are recognizing the need to change sys-
tems of care – and, importantly, people
with IDD and their advocates are push-
ing for greater access with better out-
comes. A Center for Health Care Strategies
survey (5) sent to state IDD agency direc-
tors in 2011 yielded interesting results.
Among responding states, 62% indicated
their intention to integrate medical and
behavioral health services with their long
term services and supports systems. In
addition, Michigan announced plans to
develop a Medicaid Chronic Care Health
Home Project, a demonstration project
that is intended to improve efficiency
and effectiveness of healthcare and reduce
health care costs. Patient-centered med-
ical homes (or health homes) are primary
healthcare practices that provide compre-
hensive whole-person care to those they
serve: children,adults, seniors,and families,
including recommended preventative care
and chronic disease management. Med-
ical homes offer coordinated care across
the healthcare system, including specialists,
hospitals, long term service systems, and
patients’ natural support communities.
These important initiatives suggest states’
recognition of the need to innovate and
make more efficient their healthcare deliv-
ery and financing systems. Bachman et al.
(6) provided a good overview of US state-
based publicly financed healthcare options.
There are also important opportuni-
ties for healthcare delivery systems to
be built on a federally qualified health
center (FQHC) platform, where reim-
bursements are cost-based (versus fee-
for-service). FQHCs qualify for enhanced
reimbursement from Medicare and Medic-
aid, as well as other benefits. FQHCs must
serve an underserved area or population,
offer a sliding fee scale, provide compre-
hensive services, have an ongoing quality
assurance program, and have a govern-
ing board of directors. Most metropolitan
areas of the US are supported by FQHCs,
thus representing a reasonably accessible
means of healthcare for people with IDD.
This does not guarantee that an FQHC will
employ providers who are expert in the
treatment of people with IDD; however, to
the extent such expertise can be developed
within an FQHC, it is a promising oppor-
tunity to overcome some of the financially
driven access barriers for people with IDD.
Leadership education in neurodevel-
opmental and related disabilities (LEND)
programs offer another highly regarded
model that provides, among other things,
interdisciplinary care intended to improve
the health of people with IDD. These
programs, which are typically a compo-
nent of a university center for excellence
in developmental disabilities education,
research and service (UCEDD), work in
collaboration with local university hos-
pitals or health care centers. While each
LEND program is unique, they share the
following objectives:
• advancing the knowledge and skills of
all child health professionals to improve
healthcare delivery systems for children
with IDD
• providing high-quality interdisciplinary
education that emphasizes the integra-
tion of services from state and local agen-
cies and organizations, private providers,
and communities
• providing health professionals with skills
that foster community-based partner-
ships and
• promoting innovative practices to
enhance cultural competency, family-
centered care, and interdisciplinary
partnerships.
The LENDs are federally funded under
the 2006 Combating Autism Act and are
administered by the Health Resources and
Service’s Administration’s Maternal and
Child Health Bureau of the US govern-
ment (7). There are fewer than 50 LEND
programs in the United States.
Managed care also holds promise as
a vehicle for healthcare delivery alterna-
tives. In particular, Medicaid managed care,
reviewed as long ago as 15 years ago in the
context of healthcare and long term ser-
vices and support for people with IDD
(8), is finding increasing popularity as a
way to manage healthcare financing. In
the last decade, as budget pressures have
mounted, US healthcare financing policy
has shifted toward enrolling Medicaid ben-
eficiaries with disabilities into managed
care. Medicaid managed care, in addition
to promising more efficient use of finite
healthcare financing, also offers the poten-
tial for improvements in coordination of
care for Medicaid enrollees, particularly
those with complex needs (9). Medicaid
managed care does not come without some
controversy. Concerns from people with
IDD, their families, and advocates focus on
quality of care and who is making deci-
sions on what healthcare can be accessed.
Such concerns are consistent with broad
historical perceptions that managed care
systems deny necessary care and provide
lower quality care (10).
Beyond these models, there are addi-
tional considerations. With PPACA in the
United States, it is required that indi-
vidual and small private insurance group
plans cover certain benefits that have pre-
viously not been widely available,“rehabili-
tative and habilitative services and devices.”
While private health plans have tradition-
ally covered rehabilitative services that are
designed around recovery from a traumatic
health event, the health law now requires
coverage of similar services to help peo-
ple learn or maintain functional skills. This
important advancement in coverage stan-
dards holds substantial promise for peo-
ple with IDD. In individual states over the
past ten years, there have been concerted
efforts in state legislatures to carve out
and mandate certain private insurance cov-
erage – particularly for therapies such as
applied behavior analysis for children with
Autism – to support people with IDD and
their families in accessing the healthcare
they need to thrive.
CONCLUSION
The high cost of healthcare for people with
IDD is not new. People with IDD are far
more likely than their typically develop-
ing peers to experience health disparities,
disproportionally higher rates of chronic
disease, and less access to preventative pri-
mary care and health promotion resources.
The result is that people with IDD tend to
access the healthcare system at a point when
care and treatment will be more extensive
and therefore more costly. This need not
be the case. As healthcare financing systems
continue to evolve, more should be done to
link them to both preventative healthcare
and health promotion needs and identified
priority outcomes of people with IDD:
• Care coordination that considers acute
health needs and service, long term ser-
vice and supports, and a person’s array
of natural and community supports
remains a needed service for people with
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IDD to fully address complex health-
care conditions that require services from
multiple providers and specialty types. A
feature of Medicaid managed care sys-
tems, care coordination supports people
with IDD and their families in accessing
and receiving needed healthcare from a
potentially expansive range of healthcare
outlets, while promoting a more cost-
effective and efficient use of healthcare
resources. Consistent with this needed
focus on care coordination, expansion of
the health home model (11) for people
with IDD should occur.
• As envisioned in the PPACA, healthcare
reimbursements (both public and pri-
vate) should be linked with patient out-
comes. Fee-for-service systems have cre-
ated incentives for healthcare providers
to perform treatments and procedures,
versus for health outcomes experienced
by people. In addition, capitation or uni-
versal payments for healthcare that are
directed, to the fullest extent possible
by people with IDD and their families,
should characterize healthcare financing
systems of the future that allow them
to actively participate in deciding how
and from where they will receive their
healthcare.
• Existing systems of healthcare deliv-
ery, including FQHCs and LEND pro-
grams, should be leveraged more exten-
sively. With FQHCs, cost-based reim-
bursements are superior to traditional
fee-for-service funding; and, it is well
within the US federal guidelines for
FQHCs to serve people with IDD to the
extent they are “an underserved popula-
tion.”
• As in 26 states in the US, work to create
statutorily mandated benefits that assure
children and adults covered by private
insurance have access to essential services
should continue. While the recent trend
has been toward mandated benefits or
insurance reform targeting autism (12,
13), a more expansive view of benefits
that are linked to desired health outcomes
for people with all forms of IDD should
be taken. Moreover, these efforts, which
are best led by people with IDD and
their families and advocates, should be
sustained over time to assure that man-
dated benefits packages are informed by
contemporary research and best practice.
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